BackAida Pharmaceuticals Overview

Aida Pharmaceuticals Receivables

Track Aida Pharmaceuticals's receivables ($12M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Receivables
$12.31M
↓ 1.68% YoYΔ $-210521.00 vs prior year quarter

Peer trimmed avg / median

Loading

Aida Pharmaceuticals Receivables History

Loading

Aida Pharmaceuticals vs. peers: Receivables Comparison

Loading

Aida Pharmaceuticals Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Aida Pharmaceuticals (AIDA) FAQ

Aida Pharmaceuticals (AIDA) currently reports a receivables of $12M as of September 2008. That compares with $13M in the prior-year period — down 1.7% year over year. Use the charts on this page to explore Aida Pharmaceuticals's receivables history and peer comparisons.

Aida Pharmaceuticals's receivables decreased from $13M to $12M — a 1.7% year-over-year decrease (period ending September 2008). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Aida Pharmaceuticals reported $12M in receivables as of September 2008. That compares with $13M in the prior-year period — down 1.7% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current receivables of $12M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Aida Pharmaceuticals, and consider following AIDA for alerts when major investors trade the stock.